Muscat: Data released by the Statistical Centre for the Cooperation Council for the Arab States of the Gulf shows that GCC countries achieved a significant milestone in immunisation, with coverage for essential vaccines reaching 100 per cent in 2024, compared with approximately 84 per cent globally. This reflects the effectiveness of national immunisation programmes and the strength of public health systems across the region.
According to the weekly bulletin issued on the occasion of World Health Day 2026, GCC countries continue to strengthen their leading role in supporting global health by investing in medical research and development and expanding access to affordable medicines and vaccines. The data highlights that sustained investment in health infrastructure, along with enhanced international cooperation, forms the foundation of Gulf health policies aimed at achieving universal health coverage and ensuring a sustainable, healthy future for all.
In support of global health efforts, GCC countries contributed approximately US$842.7 million to the health sector and medical research through Official Development Assistance (ODA) in 2023. This accounts for about 4.6 per cent of total international development assistance, underlining the commitment of these nations to advancing global health and sharing medical knowledge.
The bulletin emphasises that these efforts align with the Sustainable Development Goals, particularly Goal 3, which focuses on ensuring healthy lives and promoting well-being for all at all ages. It also highlights the importance of supporting scientific research as a key pillar in improving the quality of healthcare services.
Furthermore, GCC countries continue to play an active role in supporting developing nations by contributing to the development of healthcare systems and strengthening their capacity to address health challenges, while ensuring that essential medicines and vaccines are accessible to diverse populations.